2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 92% in 12 Months, According to Select Wall Street AnalystsThe Motley Fool • 10/15/24
Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming DecadeThe Motley Fool • 10/14/24
3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With Less Than $100 Right NowThe Motley Fool • 10/12/24
Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatmentMarket Watch • 10/11/24
U.S. FDA Approves Pfizer's HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without InhibitorsBusiness Wire • 10/11/24